Yes. Wasatch BioLabs provides scalable sequencing solutions built for precision clinical testing. Our services are designed for real-world clinical use, with systems like dWMS tailored for clinical-ready workflows and cohort studies.
Yes — we are certified to CLIA and we are CLEP-ready and FDA-ready. Our experienced team can help guide clients from early discovery work, through clinical validation, and into patient testing phases.
As your clinical lab partner, we have expertise and are willing to expand our regulatory scope such as with medical devices, companion diagnostics, and IVDs (ISO 13485), international clinical labs (ISO 15189), MDSAP, ISO 14197, IVDR, M.O. 169, etc.
Available sequencing services include Direct Whole Methylome Sequencing (dWMS), Direct Targeted Methylation Sequencing, biomarker discovery, custom assay development, and standard Oxford Nanopore Technologies (ONT) services—supporting both genomic, epigenomic, and transcriptomic profiling.
To get started, visit the Wasatch BioLabs website and explore their service offerings. You can also reach out via their Contact page or subscribe for updates. They provide custom support across research and clinical applications.
